[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE321553T1 - Arzneimittel für hinterstrangataxie und zusammensetzung zur behandlung von hinterstrangataxie - Google Patents

Arzneimittel für hinterstrangataxie und zusammensetzung zur behandlung von hinterstrangataxie

Info

Publication number
ATE321553T1
ATE321553T1 AT99923887T AT99923887T ATE321553T1 AT E321553 T1 ATE321553 T1 AT E321553T1 AT 99923887 T AT99923887 T AT 99923887T AT 99923887 T AT99923887 T AT 99923887T AT E321553 T1 ATE321553 T1 AT E321553T1
Authority
AT
Austria
Prior art keywords
posscular
aaxia
cord
treatment
composition
Prior art date
Application number
AT99923887T
Other languages
English (en)
Inventor
Toru Nishikawa
Keji Wada
Yasuyuki-Meiji Seika Ichimaru
Yokohama
Aiko-Meiji Seika Kaisha L Sawa
Toyokazu-Meiji Seika Hiranuma
Yokohama-Shi
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Application granted granted Critical
Publication of ATE321553T1 publication Critical patent/ATE321553T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Soft Magnetic Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AT99923887T 1998-06-10 1999-06-03 Arzneimittel für hinterstrangataxie und zusammensetzung zur behandlung von hinterstrangataxie ATE321553T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16165398 1998-06-10

Publications (1)

Publication Number Publication Date
ATE321553T1 true ATE321553T1 (de) 2006-04-15

Family

ID=15739283

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99923887T ATE321553T1 (de) 1998-06-10 1999-06-03 Arzneimittel für hinterstrangataxie und zusammensetzung zur behandlung von hinterstrangataxie

Country Status (7)

Country Link
US (1) US7067545B1 (de)
EP (1) EP1084704B1 (de)
JP (1) JP3363440B2 (de)
AT (1) ATE321553T1 (de)
DE (1) DE69930624T2 (de)
ES (1) ES2262322T3 (de)
WO (1) WO1999063989A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6884910B2 (en) 2000-08-25 2005-04-26 Research Corporation Technologies, Inc. Uses for amino acid anticonvulsants
CA2442330A1 (en) 2001-03-29 2002-10-10 Emory University Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning
JP5196641B2 (ja) * 2004-09-09 2013-05-15 塩野義製薬株式会社 脊髄小脳変性症治療剤
TWI350754B (en) 2004-09-09 2011-10-21 Shionogi & Co A pharmaceutical composition for treating spinocerebellar ataxia
KR20120041740A (ko) * 2009-09-14 2012-05-02 가부시키가이샤 시세이도 자외선 장해 경감 조성물
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
GB201403944D0 (en) * 2014-03-06 2014-04-23 Takeda Pharmaceutical New use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904681A (en) * 1987-12-01 1990-02-27 G. D. Searle & Co. D-cycloserine and its prodrugs as cognitive enhancers
US5187171A (en) * 1989-01-09 1993-02-16 G. D. Searle & Co. Use of a glycine b partial agonist as an antipsychotic
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
JPH0826986A (ja) * 1994-07-21 1996-01-30 Yamanouchi Pharmaceut Co Ltd 抗フェンサイクリジン薬
DE19612823C2 (de) 1995-03-31 2001-03-01 Mitsubishi Chem Corp Optisches Aufzeichnungsverfahren
TW372314B (en) 1996-11-25 1999-10-21 Hitachi Maxell Data recording medium and data regeneration apparatus thereof
DE69829414T2 (de) 1997-03-27 2006-01-26 Mitsubishi Chemical Corp. Optisches Informationsaufzeichnungsmedium

Also Published As

Publication number Publication date
EP1084704A1 (de) 2001-03-21
EP1084704A4 (de) 2003-07-23
JP3363440B2 (ja) 2003-01-08
EP1084704B1 (de) 2006-03-29
WO1999063989A1 (fr) 1999-12-16
ES2262322T3 (es) 2006-11-16
US7067545B1 (en) 2006-06-27
DE69930624D1 (de) 2006-05-18
DE69930624T2 (de) 2006-09-14

Similar Documents

Publication Publication Date Title
DE60117043D1 (de) Behandlung von mukositis
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
ATE267798T1 (de) Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung
BG106825A (en) Substituted oxazolidinones and their use in the field of blood coagulation
ATE277638T1 (de) Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten.
BG106095A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
FI971951A0 (fi) 2,2-dikloroalkaanikarboksyylihapot, menetelmät niiden valmistamiseksi, niitä sisältävät lääkkeet, ja niiden käyttö insuliiniresistanssin hoitoon
ATE396967T1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
ATE252389T1 (de) Ein arzneimittel zur behandlung von fettleibigkeit und verbesserung des lipidmetabolismus
DE69930271D1 (de) Medizinische zusammensetzungen zur behandlung von augenerkrankungen
ATE198550T1 (de) Verwendung von weihrauch zur behandlung der alzheimer-krankheit
BG106155A (en) Novel derivatives and analogues of galanthamin
PT1001775E (pt) Medicamento contendo ioimbina e arginina para tratamento de disfuncao erectil
ATE321553T1 (de) Arzneimittel für hinterstrangataxie und zusammensetzung zur behandlung von hinterstrangataxie
WO2004067027A3 (en) Osteogenic composition
DE60031016D1 (de) Verwendung von Antiseptika zur Herstellung von Arzneimitteln zur Prophylaxe und Behandlung von Entzündungen im Korperinneren des Menschen
IL141515A (en) Optically active pyridyl- 4h - 1, 2, 4 - oxadiazine derivative and its use in the treatment of vascular diseases and pharmaceutical composition comprising same
RU94041028A (ru) Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция
ATE183648T1 (de) Arzneimittel enthaltend mischungen von höheren primären aliphatischen alkoholen zur behandlung von hypercholesterolämie und hyperlipoproteinämie typ ii und zur stimulation des sexuellen verhaltens bei tieren und menschen
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
ATE555787T1 (de) Behandlungseffekte von überschüssigen reaktiven sauerstoffspezies
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
ATE194076T1 (de) Verwendung von n,s-diacetylcystein-ethylester (dacee) zur herstellung eines medikaments zur behandlung viraler erkrankungen
ATE131729T1 (de) 3,5-diiod-l-thyronin zur tsh-suppression und behandlung von struma
ATE108063T1 (de) Heilmittel zur behandlung von toxoplasmose.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties